Phrixotoxin-1 (TFA): A Spider Venom Peptide as a Tool in Ion Channel Research

Peptide toxins from spider venoms have long been invaluable in neuroscience and electrophysiology as high-affinity modulators of ion channels. Phrixotoxin-1 (PaTx1, sometimes listed as Phrixotoxin-1 TFA in its trifluoroacetate salt form) is one such peptide. It is known for its selective modulation of A-type (transient) voltage-gated potassium channels (especially Kv4 family). Because of its specificity and structural stability (via disulfide bonds), Phrixotoxin-1 serves as a powerful tool in studying Kv4 channel gating, cardiac excitability, neuronal excitability, and channel pharmacology.

1. Source / name: Phrixotoxin-1 (abbreviated PaTx1) is originally derived from the venom of the theraphosid spider Phrixotrichus auratus. PMC+3Wikipédia+3MedchemExpress.com+3
2. Target channels: It is a gating modifier of Kv4 family channels (Kv4.2, Kv4.3), meaning it preferentially interacts with the closed state and alters voltage dependence of activation/inactivation, rather than simply plugging the pore. Wikipédia+3PMC+3PMC+3
3. Structure / motif: Phrixotoxin-1 contains ~29 amino acids and three disulfide bonds, adopting an Inhibitory Cystine Knot (ICK) fold typical of many spider toxins. PMC+2Wikipédia+2
4. IC₅₀ / potency: In functional assays, it shows nanomolar potency in modulating Kv4 currents. PMC+3PMC+3Wiley Online Library+3
5. Salt form and notation: “TFA” refers to the trifluoroacetate salt (commonly used in peptide purification) but does not change the core peptide’s sequence or disulfide structure.

Understanding the 3D structure is critical to interpreting how Phrixotoxin-1 interacts with its target channels.

Solution NMR-derived structure of Phrixotoxin-1 (PaTx1)

This structure shows the compact ICK fold, with disulfide bridges stabilizing its shape, and exposes surface residues and electrostatic patches predicted to interface with Kv4 channels. Wiley Online Library+1

From structural studies (Chagot et al., 2004) and follow-up work:

1. The toxin exhibits electrostatic anisotropy (i.e. dipole moment) and hydrophobic/aromatic surface patches that likely mediate binding to the S3–S4 voltage sensor region of Kv4 channels. PMC+1
2. The arrangement of cysteines and disulfide bonds (Cys2–Cys16, Cys9–Cys21, Cys15–Cys25) locks the fold and constrains flexibility, giving the toxin rigidity that is favorable for channel binding. Alomone Labs+2PMC+2

A second figure helps show how Phrixotoxin-1 compares among spider toxin folds:

Comparative structural models of spider venom peptide toxins, including Phrixotoxin-1 (PaTx1) in ICK fold context

This kind of comparative depiction emphasizes shared fold features (six cysteines) and the spatial orientation of functional surfaces.

These structural features underlie how Phrixotoxin-1 can selectively bind and alter the voltage sensor region of Kv4 channels, rather than blocking the pore.

Phrixotoxin-1 is not a simple blocker; its action is nuanced and involves modulation of gating:

1. Gating modifier: It preferentially binds to the closed state (or near it), stabilizing that conformation and thereby shifting voltage dependence of activation to more depolarized potentials. PMC+2PMC+2
2. Effect on kinetics: It prolongs the time to peak current and slows inactivation kinetics in many cases, altering the amplitude and timing of A-type currents. PMC+2PMC+2
3. Voltage-dependence shift: The conductance-voltage (G–V) curve is shifted rightward (requiring greater depolarization) in presence of toxin. PMC+2PMC+2
4. Selectivity: It is more selective for Kv4.2 / Kv4.3 isoforms over many other potassium channel families, which makes it useful for dissecting roles of A-type currents in neurons or cardiac tissue. Wikipédia+3MedchemExpress.com+3PMC+3

In a representative study, Phrixotoxin-1 application to Xenopus oocytes expressing Kv4.2 significantly suppressed currents and altered gating, illustrating its utility in ex vivo / in vitro electrophysiology. Alomone Labs+2MedchemExpress.com+2

Because of these properties, Phrixotoxin-1 is often used to probe the physiological contribution of A-type potassium currents (I_A) in neurons, cardiac cells, and excitable systems.

When working with Phrixotoxin-1 (TFA), several technical considerations are important:

-Peptide purity and folding

Ensure proper disulfide bond formation (correct pairing) and check by mass spectrometry or HPLC.

Avoid oxidation or mis-pairing that can impair binding.

-Concentration and dosing

Start from nanomolar to low micromolar ranges; verify a dose–response curve.

Pre-equilibrate before measurement, and allow sufficient wash periods for reversibility studies.

-Channel expression system

Use well-characterized expression systems (e.g. Xenopus oocytes, HEK293, CHO) with defined expression levels of Kv4.2 / Kv4.3.

Confirm that the cell line does not express interfering endogenous K+ currents.

-Temperature, voltage protocols, timing

Gating shifts are often sensitive to temperature and voltage clamp protocol.

Use consistent voltage-step or ramp protocols for comparability.

-Control experiments

Always run vehicle and mock conditions.

Test toxin specificity by applying to non-Kv4 expressing channels.

Use mutant Kv4 channels with known alterations in gating to validate binding hypotheses.

-Stability & storage

Store lyophilized peptide at −20 °C or lower, desiccated.

Reconstitute fresh or freeze aliquots to avoid multiple freeze–thaw cycles.

-Safety & handling

Though used only in research-grade settings, treat as bioactive toxin: use gloves, eye protection, avoid accidental exposure.

By carefully controlling these parameters, experiments can harness the selective modulating properties of Phrixotoxin-1 to elucidate channel physiology.

At Gentaur, we provide high-purity Phrixotoxin-1 (TFA) to support cutting-edge electrophysiology and ion-channel research.

Our product is specifically formulated for researchers studying Kv4-family potassium channels and transient outward currents (I_A / I_to) in neuronal and cardiac systems.

🔗 Order directly from Gentaur:

👉 Phrixotoxin-1 (TFA) – Product Page

Gentaur’s Phrixotoxin-1 (TFA) is supplied in a ready-to-use lyophilized form with certified specifications ensuring structural integrity and reproducible biological activity.

✅ Product Highlights

1. Verified peptide sequence with correct disulfide connectivity (Inhibitory Cystine Knot, ICK fold)
2. Purity ≥ 95% (HPLC confirmed) and mass-spectrometry verified molecular weight
3. Functionally validated for modulation of Kv4.2/Kv4.3 currents in electrophysiological systems
4. Trifluoroacetate (TFA) salt form for long-term stability and high solubility
5. Delivered with Certificate of Analysis (COA) for identity, purity, and activity assurance
6. Batch-to-batch consistency guaranteed for reproducible experimental results

Researchers choose Gentaur because of our commitment to quality, traceability, and fast global delivery. Each batch of Phrixotoxin-1 is carefully produced and tested to ensure optimal folding and biological performance, making it suitable for high-precision applications in:

1. Patch-clamp studies of Kv4 gating kinetics
2. Action potential modeling in cardiomyocytes
3. Screening of channel inhibitors or modulators
4. Neuroscience research on A-type current dynamics

For more details or technical support, contact [email protected] — our scientific team can provide datasheets, COA, and guidance on optimal storage, reconstitution, and experimental use.